Intrahepatic islet transplantation is a promising β-cell replacement strategy for the treatment
of type 1 diabetes. Instant blood-mediated inflammatory reactions, acute inflammatory storm …

Type 1 diabetes (T1D) is an autoimmune disease caused by the immune system attacking
and destroying insulin-producing β cells in the pancreas. Islet transplantation is becoming …

Microencapsulation is a promising strategy to prolong the survival and function of
transplanted pancreatic islets for diabetes therapy, albeit its translation has been impeded …

Pancreatic islets transplantation is an optimal alternative to exogenous insulin injection for
long-term effective type 1 diabetes treatment. However, direct islets transplantation without …

Type 1 diabetes mellitus (T1DM) is characterized by absolute insulin deficiency primarily
due to autoimmune destruction of pancreatic β‐cells. The prevailing treatment for T1DM …

Microfluidic encapsulation of cells/tissues in hydrogel microcapsules has attracted
tremendous attention in the burgeoning field of cell‐based medicine. However, when …

Islet allotransplantation offers a promising cell therapy for type 1 diabetes, but challenges
such as limited donor availability and immunosuppression persist. Microencapsulation of …

Islets transplantation is a promising method to treat type 1 diabetes. Unfortunately, current
islet encapsulation and transplantation strategies are difficult to simultaneously achieve the …

Insulin-secreting allogeneic cell therapies are a promising treatment for type 1 diabetes, with
the potential to eliminate hypoglycemia and long-term complications of the disease …

Single-cell nanoencapsulation is a method of coating the surface of single cell with
nanomaterials. In the early 20th century, with the introduction of various types of organic or …